June 29, 2015 | The international healthcare company Merck announced that it will acquire Qlight Nanotech. Though the financial details of the deal were not disclosed, Merck will require the remaining stake in the Jerusalem-based company to control 100 percent of the company. Qlight Nanotech is the developer of semiconductor nanocyrstals and Merck hopes to use their technology to develop liquid crystal displays and OLED technology. The deal was announced at today’s (Monday’s) ‘Made in Germany’ event in Tel Aviv.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments